Canada Life’s Sophiris Bio, Inc. SPHS Stock Holding History

Canada Life’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-8,087	Closed	-$35K	–	2316
2013 Q3	$35K	Buy	+8,087	New	+$37.3K	﹤0.01%	1059

Other funds holding SPHS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Canada Life's SPHS Position: Q4 2013 in Review

Canada Life sold out of Sophiris Bio, Inc. (SPHS) in Q4 2013, closing a stake of 8,087 shares — an estimated $35K sold.

Canada Life first reported a position in SPHS in Q3 2013 and held it in 1 quarter. The position peaked at $35K in Q3 2013. 22 funds tracked by Wall St. Rank hold SPHS as of Q4 2013.

Canada Life reported no remaining Sophiris Bio, Inc. position as of Q4 2013 after selling out during the quarter.
Canada Life sold 8,087 Sophiris Bio, Inc. shares in Q4 2013, an estimated $35K.
Canada Life first reported a position in Sophiris Bio, Inc. in Q3 2013 and held it in 1 quarter.
Canada Life's Sophiris Bio, Inc. position peaked at $35K in Q3 2013.
22 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q4 2013.

Based on Canada Life's 13F filing for Q4 2013, filed 31 Jan 2014.